[Updated] UK SACT Board: Good Practice Guidance for Immuno-Oncology Medicines

UK SACT Board

 

Good Practice Guidance for Immuno-Oncology Medicines – May 2024

The UK SACT Board’s Good Practice Guidance for Immuno-Oncology Medicines has been updated.

This guideline is designed to give a practical framework for the safe introduction and ongoing use of immunotherapy in existing Systemic Anti-Cancer Therapy (SACT) services.

This guideline is available on the UK SACT Board publication page: https://www.uksactboard.org/publications

Latest News

By BOPA Executive Committee on 23rd June 2025

Meet the Board Members Webinars – Hosted by the UK Pharmacy Professional Leadership Advisory Board

The UK Pharmacy Professional Leadership Advisory Board (UKPPLAB) is leading development of a collaborative, inclusive, and effective model of pharmacy professional leadership (PPL) across the UK. Eight UK PPL organisations have…

Read article
By BOPA Research committee on 18th June 2025

Share Your Insights – The use and development of ChemoCare Electronic Prescribing System for systemic anti-cancer therapy

Dear Oncology/Haematology Pharmacist, You are invited to participate in a survey exploring the factors that influence UK-registered pharmacists’ use and the development of ChemoCare Electronic Prescribing system (EPS) for systemic…

Read article
By BOPA Education & Training Sub-Committee on 17th June 2025

New CINV e-learning module

The Education and Training subcommittee are pleased to announce that our new e-learning module for Chemotherapy-induced Nausea and Vomiting (CINV) is now live on the BOPA website. The module can…

Read article
By BOPA E&T Subcommittee on 12th June 2025

BOPA E&T Webinar: Harnessing AI in Oncology Pharmacy Practice – Focus on Administrative Efficiency

Friday 20th June 2025 at 12:00 BST   Click HERE to register   The BOPA Education and Training Subcommittee would like to invite you to the E&T Webinar: Harnessing AI…

Read article